• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种导致肢端肥大症诊断的罕见甲状腺功能亢进症:病例报告。

A rare form of hyperthyroidism leading to the diagnosis of acromegaly: A case report.

作者信息

Plotuna Iulia-Ștefania, Balaş Melania, Golu Ioana, Amzăr Daniela, Cornianu Mărioara, Vărcus Flore, Vlad Adrian, Vlad Mihaela

机构信息

Second Department of Internal Medicine, Discipline of Endocrinology, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of Endocrinology, 'Pius Brinzeu' Emergency County Hospital, 300736 Timisoara, Romania.

出版信息

Exp Ther Med. 2023 Aug 22;26(4):477. doi: 10.3892/etm.2023.12176. eCollection 2023 Oct.

DOI:10.3892/etm.2023.12176
PMID:37664685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10469149/
Abstract

Acromegaly is a rare disease, usually caused by a pituitary tumor. It typically exhibits slow evolution and can result in numerous complications. In the present case report, the patient presented with hyperthyroidism associated with ophthalmopathy and right nodular goiter. The laboratory tests revealed persistent high levels of phosphorus without an apparent cause. After ruling out common pathologies associated with this finding, a focus was placed on the clinical aspects associated with acromegaly, a rare cause of hyperphosphatemia. Laboratory tests and MRI confirmed the diagnosis. The patient underwent transsphenoidal surgery, but the disease remained active, thus medical treatment was initiated, to a poor initial response. Associated with acromegaly, two distinct thyroid pathologies were diagnosed: Toxic adenoma and Graves' disease. This case highlights the challenges in diagnosing and managing a rare endocrine pathology.

摘要

肢端肥大症是一种罕见疾病,通常由垂体肿瘤引起。其病程通常进展缓慢,并可导致多种并发症。在本病例报告中,患者表现为伴有眼病和右叶结节性甲状腺肿的甲状腺功能亢进。实验室检查显示磷水平持续升高但无明显原因。在排除与此发现相关的常见病理情况后,重点关注与肢端肥大症相关的临床方面,肢端肥大症是高磷血症的罕见病因。实验室检查和磁共振成像(MRI)确诊了该疾病。患者接受了经蝶窦手术,但疾病仍处于活跃状态,因此开始进行药物治疗,初期反应不佳。与肢端肥大症相关,诊断出两种不同的甲状腺疾病:毒性腺瘤和格雷夫斯病。本病例突出了诊断和管理罕见内分泌疾病的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/848b4efa77c7/etm-26-04-12176-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/52b64d5142d5/etm-26-04-12176-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/a211f61bbdf5/etm-26-04-12176-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/1d56897abd05/etm-26-04-12176-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/0cb41e5927f9/etm-26-04-12176-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/308121c1c7c7/etm-26-04-12176-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/6d1af6028e64/etm-26-04-12176-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/446ae5be9bae/etm-26-04-12176-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/d0de98eed60f/etm-26-04-12176-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/848b4efa77c7/etm-26-04-12176-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/52b64d5142d5/etm-26-04-12176-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/a211f61bbdf5/etm-26-04-12176-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/1d56897abd05/etm-26-04-12176-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/0cb41e5927f9/etm-26-04-12176-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/308121c1c7c7/etm-26-04-12176-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/6d1af6028e64/etm-26-04-12176-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/446ae5be9bae/etm-26-04-12176-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/d0de98eed60f/etm-26-04-12176-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a13/10469149/848b4efa77c7/etm-26-04-12176-g08.jpg

相似文献

1
A rare form of hyperthyroidism leading to the diagnosis of acromegaly: A case report.一种导致肢端肥大症诊断的罕见甲状腺功能亢进症:病例报告。
Exp Ther Med. 2023 Aug 22;26(4):477. doi: 10.3892/etm.2023.12176. eCollection 2023 Oct.
2
Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.格雷夫斯病甲亢和毒性结节性甲状腺肿治疗后生活质量损害持续六个月:一项前瞻性队列研究。
Thyroid. 2016 Aug;26(8):1010-8. doi: 10.1089/thy.2016.0044.
3
[Clinical aspects, diagnosis and drug therapy of hyperthyroidism].[甲状腺功能亢进症的临床症状、诊断及药物治疗]
Schweiz Med Wochenschr. 1995 Aug 8;125(31-32):1489-94.
4
[Manifestation of Graves' disease, resulting from radiosurgical treatment of acromegaly, in a patient with panhypopituitarism].[垂体功能减退患者因肢端肥大症接受放射外科治疗后出现格雷夫斯病的表现]
Probl Endokrinol (Mosk). 2019 Jun 30;65(2):101-106. doi: 10.14341/probl10026.
5
Association of an empty sella and grave´s disease in a patient with acromegaly: a case report.空蝶鞍与格雷夫斯病在肢端肥大症患者中的关联:病例报告。
Pan Afr Med J. 2021 Apr 22;38:394. doi: 10.11604/pamj.2021.38.394.25034. eCollection 2021.
6
A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.一例 Graves 病引起的甲状腺功能亢进症,随后可能是 TSH 瘤——病例报告。
BMC Endocr Disord. 2020 Aug 27;20(1):133. doi: 10.1186/s12902-020-00611-7.
7
Frequency of Pathological Types of Hyperthyroidism in Thyroid Scan Patients.甲状腺扫描患者中甲状腺功能亢进症的病理类型频率。
Curr Med Imaging. 2021;17(5):608-612. doi: 10.2174/1573405616666201118142752.
8
Sequential occurrence of toxic nodular goiter followed by Graves' disease.
Endocr Pract. 1998 May-Jun;4(3):150-2. doi: 10.4158/EP.4.3.150.
9
A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter.格雷夫斯病和毒性结节性甲状腺肿患者眼动脉和视网膜中央动脉多普勒血流参数的比较
Front Endocrinol (Lausanne). 2019 Oct 17;10:707. doi: 10.3389/fendo.2019.00707. eCollection 2019.
10
Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.胫前黏液水肿伴无眼病:Graves 病的首发表现。
Am J Med Sci. 2013 Jul;346(1):73-5. doi: 10.1097/MAJ.0b013e318288a6fa.

本文引用的文献

1
Extraocular Muscle Enlargement in Growth Hormone-Secreting Pituitary Adenomas.生长激素型垂体腺瘤眼外肌增粗。
AJNR Am J Neuroradiol. 2022 Apr;43(4):597-602. doi: 10.3174/ajnr.A7453. Epub 2022 Mar 17.
2
Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center.肢端肥大症患者甲状腺结节性疾病的相关危险因素:一家三级医院的病例队列研究。
Growth Horm IGF Res. 2021 Oct-Dec;60-61:101431. doi: 10.1016/j.ghir.2021.101431. Epub 2021 Oct 12.
3
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
2021 年欧洲 Graves 眼病专家组(EUGOGO)Graves 眼病医学管理临床实践指南。
Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.
4
Global epidemiology of acromegaly: a systematic review and meta-analysis.肢端肥大症的全球流行病学:系统评价和荟萃分析。
Eur J Endocrinol. 2021 Jul 1;185(2):251-263. doi: 10.1530/EJE-21-0216.
5
Thyroid gland changes in patients with acromegaly.肢端肥大症患者的甲状腺变化。
Arch Endocrinol Metab. 2020 May-Jun;64(3):269-275. doi: 10.20945/2359-3997000000247.
6
Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality.肢端肥大症的诊断延迟时间延长与发病率和死亡率的增加有关。
Eur J Endocrinol. 2020 Jun;182(6):523-531. doi: 10.1530/EJE-20-0019.
7
Serum phosphate: Does it more closely reflect the true state of acromegaly?血清磷酸盐:它是否更能反映肢端肥大症的真实状态?
J Clin Neurosci. 2020 Jan;71:26-31. doi: 10.1016/j.jocn.2019.11.012. Epub 2019 Dec 16.
8
Graves' disease, multinodular goiter and subclinical hyperthyroidism.格雷夫斯病、多结节性甲状腺肿和亚临床甲状腺功能亢进。
Ann Endocrinol (Paris). 2019 Sep;80(4):240-249. doi: 10.1016/j.ando.2018.09.004. Epub 2018 Sep 25.
9
Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?肢端肥大症中心血管合并症的最新进展。我们应如何诊断和管理这些合并症?
Front Endocrinol (Lausanne). 2019 Mar 7;10:120. doi: 10.3389/fendo.2019.00120. eCollection 2019.
10
PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE.肢端肥大症术后医学管理的预测标志物:系统评价和共识治疗指南。
Endocr Pract. 2019 Apr;25(4):379-393. doi: 10.4158/EP-2018-0500. Epub 2019 Jan 18.